FDA Expands Enhertu Indication to HER2-Positive Solid Tumors
The US Food and Drug Administration (FDA) has expanded the approval of fam-trastuzumab–deruxtecan-nxki (Enhertu; AstraZeneca and Daiichi Sankyo, Inc) to ...
Read moreDetailsThe US Food and Drug Administration (FDA) has expanded the approval of fam-trastuzumab–deruxtecan-nxki (Enhertu; AstraZeneca and Daiichi Sankyo, Inc) to ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info